Brief: FDA Requests Supplementary Information For Acarix Breakthrough Designation Request For Heart Failure Diagnosis

Acarix AB

01/04/2022 07:35

April 1 (Reuters) - Acarix AB  ACARIX.ST :
    * REG-FDA REQUESTS SUPPLEMENTARY INFORMATION FOR ACARIX
BREAKTHROUGH DESIGNATION REQUEST FOR HEART FAILURE DIAGNOSIS

Source text for Eikon:  ID:nGNEb3FxPv 
Further company coverage:  ACARIX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))